Bristol-Myers Squibb Company - Strategy, SWOT and Corporate Finance Report

November 2023 | 55 pages | ID: BBC585F059CEN
MarketLine

Abstracts

Bristol-Myers Squibb Company %li%Strategy, SWOT and Corporate Finance Report

Summary

Bristol-Myers Squibb Company %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Bristol-Myers Squibb Company (BMS or 'the company') is a global biopharmaceutical company. The company is involved in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of innovative medicines. It develops medicines in various therapeutic areas that primarily include cardiovascular and oncology. BMS markets its products under Baraclude, Sustiva, Reyataz, Plavix, Pomalyst, Sustiva, Reblozyl, Opdivo, Eliquis, Orencia, Sprycel, Yervoy, and Empliciti brand names. The company sells products worldwide to wholesalers, retail pharmacies, hospitals, and government entities. It has business presence across the Americas, Europe, and other regions of the world. The company is headquartered in New York City, New York, the US.

Scope

• Detailed information on Bristol-Myers Squibb Company required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Bristol-Myers Squibb Company in the form of a SWOT analysis
• An in-depth view of the business model of Bristol-Myers Squibb Company including a breakdown and examination of key business segments
• Intelligence on Bristol-Myers Squibb Company's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Bristol-Myers Squibb Company, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of Bristol-Myers Squibb Company and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Bristol-Myers Squibb Company as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Bristol-Myers Squibb Company's business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
Bristol-Myers Squibb Company: Company Overview
Bristol-Myers Squibb Company: Overview and Key Facts
Bristol-Myers Squibb Company: Overview
Bristol-Myers Squibb Company: Key Facts
Bristol-Myers Squibb Company: Key Employees
Bristol-Myers Squibb Company: Key Employee Biographies
Bristol-Myers Squibb Company: Major Products and Services
Bristol-Myers Squibb Company: Management Statement
Bristol-Myers Squibb Company: Locations and Subsidiaries
Bristol-Myers Squibb Company: Key Competitors
Bristol-Myers Squibb Company: Company Analysis
Bristol-Myers Squibb Company: Business Description
Bristol-Myers Squibb Company: SWOT Analysis
Bristol-Myers Squibb Company: SWOT Overview
Bristol-Myers Squibb Company: Strengths
Bristol-Myers Squibb Company: Weaknesses
Bristol-Myers Squibb Company: Opportunities
Bristol-Myers Squibb Company: Threats
Bristol-Myers Squibb Company: Corporate Financial Deals Activity
Bristol-Myers Squibb Company: Financial Deals Overview
Bristol-Myers Squibb Company: Targets and Partners
Bristol-Myers Squibb Company: Top Deals 2019 - 2023YTD*
Bristol-Myers Squibb Company: Advisors
Bristol-Myers Squibb Company: Top Legal Advisors
Bristol-Myers Squibb Company: Top Financial Advisors
Bristol-Myers Squibb Company: Mergers and Acquisitions
Bristol-Myers Squibb Company: Corporate Venturing
Bristol-Myers Squibb Company: Capital Raising
Bristol-Myers Squibb Company: Partnership
Bristol-Myers Squibb Company: Divestments
Bristol-Myers Squibb Company: Recent Developments
Bristol-Myers Squibb Company: News and Events Summary
Bristol-Myers Squibb Company: Business Expansion
Bristol-Myers Squibb Company: Financial Deals
Bristol-Myers Squibb Company: Market Developments
Bristol-Myers Squibb Company: Red Flags/DistressSignals
Bristol-Myers Squibb Company: Research & Development
Bristol-Myers Squibb Company: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Bristol-Myers Squibb Company: Key Facts
Table 2: Bristol-Myers Squibb Company: Key Employees
Table 3: Bristol-Myers Squibb Company: Locations and Subsidiaries
Table 4: Bristol-Myers Squibb Company: Key Competitors
Table 5: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Bristol-Myers Squibb Company: M&A Activity by Geography (TTM*)
Table 7: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Bristol-Myers Squibb Company: M&A Average Deal Size - Value (US$m)
Table 9: Bristol-Myers Squibb Company: Targets and Partners
Table 10: Bristol-Myers Squibb Company: Top Deals 2019 - 2023YTD*
Table 11: Bristol-Myers Squibb Company: Legal Advisor Ranking by Value (US$m)
Table 12: Bristol-Myers Squibb Company: Financial Advisor Ranking by Value (US$m)
Table 13: Bristol-Myers Squibb Company: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: Bristol-Myers Squibb Company: M&A Activity by Geography (2019 - YTD*2023)
Table 15: Bristol-Myers Squibb Company: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: Bristol-Myers Squibb Company: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: Bristol-Myers Squibb Company: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: Bristol-Myers Squibb Company: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: Bristol-Myers Squibb Company: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: Bristol-Myers Squibb Company: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: Bristol-Myers Squibb Company: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: Bristol-Myers Squibb Company: Divestments by Geography (2019 - YTD*2023)
Table 23: Bristol-Myers Squibb Company: News and Events Summary
Table 24: Bristol-Myers Squibb Company: Business Expansion
Table 25: Bristol-Myers Squibb Company: Financial Deals
Table 26: Bristol-Myers Squibb Company: Market Developments
Table 27: Bristol-Myers Squibb Company: Red Flags/DistressSignals
Table 28: Bristol-Myers Squibb Company: Research & Development
Table 29: Bristol-Myers Squibb Company: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Bristol-Myers Squibb Company: M&A Activity by Geography (TTM*)
Figure 3: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: Bristol-Myers Squibb Company: M&A Average Deal Size - Value (US$m)
Figure 5: Bristol-Myers Squibb Company: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: Bristol-Myers Squibb Company: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: Bristol-Myers Squibb Company: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: Bristol-Myers Squibb Company: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: Bristol-Myers Squibb Company: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: Bristol-Myers Squibb Company: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: Bristol-Myers Squibb Company: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: Bristol-Myers Squibb Company: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: Bristol-Myers Squibb Company: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 14: Bristol-Myers Squibb Company: Divestments by Geography (2019 - YTD*2023)